Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Virology|April 28, 1997
Recombinant HIV envelope expressed in an alpha-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functionalE Fenouillet, M J Papandréou, I M Jones
European Journal of Biochemistry|March 30, 1999
Intracellular degradation of the HIV-1 envelope glycoprotein. Evidence for, and some characteristics of, an endoplasmic reticulum degradation pathwayJ Courageot, E Fenouillet, P Bastiani, et al.
The Journal of Infectious Diseases|February 22, 2001
The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell bindingE Fenouillet, R Barbouche, J Courageot, et al.
AIDS Research and Human Retroviruses|February 13, 2002
Pharmacophore determination of a gp120 C terminal-derived anti-HIV peptide construct interfering with membrane fusion suggesting that processing of the gp120 C terminus is a prelude to fusionR Barbouche, E Feyfant, B Belhaj, et al.
FEBS Letters|January 29, 1996
Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditionsM J Papandreou, T Idziorek, R Miquelis, et al.
Clinical and Experimental Immunology|March 1, 1995
Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activityE Fenouillet, N Blanes, A Benjouad, et al.
Virology|January 10, 1995
Multibranched peptide constructs derived from the V3 loop of envelope glycoprotein gp120 inhibit human immunodeficiency virus type 1 infection through interaction with CD4A Benjouad, F Chapuis, E Fenouillet, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 2, 1999
SPC3, an anti-HIV peptide construct derived from the viral envelope, binds and enters HIV target cellsR Barbouche, R Miquelis, J M Sabatier, et al.
AIDS Research and Human Retroviruses|December 1, 1993
Relationship between anti-p24 antibody levels and p24 antigenemia in HIV-infected patientsE Fenouillet, N Blanes, A Coutellier, et al.
FEBS Letters|March 21, 1994
Effect of sialic acid removal on the antibody response to the third variable domain of human immunodeficiency virus type-1 envelope glycoproteinA Benjouad, K Mabrouk, J C Gluckman, et al.
Pageof 5